| Description | Neladenoson dalanate (Neladenoson bialanate; BAY-1067197) is an orally active partial agonist precursor targeting the Adenosine A1 Receptor, demonstrating a favorable pharmacokinetic and safety profile. It is indicated for the management of chronic heart diseases. |
| Synonyms | Neladenoson bialanate ; BAY-1067197, BAY-1067197, Neladenoson bialanate |
| molecular weight | 716.27 |
| Molecular formula | C35H34ClN7O4S2 |
| CAS | 1239309-58-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |